General

Canadian Cancer Trials Group CO.21 Trial Newsletter

The May 2009 edition of the Canadian Cancer Trials Group CO.21 Trial Newsletter is now available. To view the newsletter, please follow this link ... http://www.ctg.queensu.ca/trials/gastro-intestinal/co21/newsletters/CO21-PACNewsletterMAY2009.pdf Also, congratulations to the Cancer Centre of Southeastern Ontario in Kingston for enrolling the study's first participant! Canadian Cancer Trials Group CO.21 is a Phase III randomized controlled study of the impact of a physical activity program on disease-free survival in patients with high risk stage II or stage III colon cancer. For complete information about CO.21, please visit the trial website at http://www.ctg.queensu.ca/trials/gastro-intestinal/co21/co21.html.